bioAffinity Technologies, Inc. (BIAF)
NASDAQ: BIAF · IEX Real-Time Price · USD
2.170
-0.050 (-2.25%)
At close: Jul 2, 2024, 4:00 PM
2.270
+0.100 (4.61%)
After-hours: Jul 2, 2024, 7:55 PM EDT

bioAffinity Technologies Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Year
Current2023202220212020
Market Capitalization
251413--
Market Cap Growth
20.00%4.34%---
Enterprise Value
241321010
PE Ratio
--1.76-1.64--
PS Ratio
5.125.522788.17--
PB Ratio
4.812.881.21--
P/FCF Ratio
-2.79-2.31-3.12--
P/OCF Ratio
-2.80-2.31-3.29--
EV/Sales Ratio
4.935.03464.21--
EV/EBITDA Ratio
-2.30-1.67-0.40-1.88-1.45
EV/EBIT Ratio
-2.20-1.62-0.40-1.88-1.44
EV/FCF Ratio
-2.65-2.10-0.52-4.88-4.49
Debt / Equity Ratio
0.280.330.02-0.72-0.66
Debt / EBITDA Ratio
-0.19-0.21-0.04-2.14-1.46
Debt / FCF Ratio
-0.22-0.26-0.06-5.55-4.53
Quick Ratio
2.021.6210.030.100.01
Current Ratio
2.221.7710.510.110.01
Asset Turnover
0.560.270.000-
Interest Coverage
-140.53-212.23-2.22-5.31-18.01
Return on Equity (ROE)
-132.80%-107.20%330.50%41.00%-
Return on Assets (ROA)
-94.70%-84.10%-114.30%-791.30%-
Return on Capital (ROIC)
-123.83%-123.93%-35.51%49.86%51.41%
Earnings Yield
-33.07%-56.80%-60.89%--
FCF Yield
-27.22%-43.37%-32.04%--
Buyback Yield / Dilution
-17.57%-94.43%-68.17%-0.01%-
Total Shareholder Return
-17.57%-94.43%-68.17%-0.01%-
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).